• 4559 Citations
  • 35 h-Index
1991 …2020
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Francesco Merli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 51 Similar Profiles
Hodgkin Disease Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Vincristine Medicine & Life Sciences
Prednisone Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences
Stem Cell Transplantation Medicine & Life Sciences
Bleomycin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2020

  • 4559 Citations
  • 35 h-Index
  • 142 Article
  • 1 Letter

Texture analysis and multiple-instance learning for the classification of malignant lymphomas

Lippi, M., Gianotti, S., Fama, A., Casali, M., Barbolini, E., Ferrari, A., Fioroni, F., Iori, M., Luminari, S., Menga, M., Merli, F., Trojani, V., Versari, A., Zanelli, M. & Bertolini, M., Mar 2020, In : Computer Methods and Programs in Biomedicine. 185, 105153.

Research output: Contribution to journalArticle

Atypical cutaneous lesions in advanced-stage Hodgkin lymphoma: A case report

Massaro, F., Ferrari, A., Zendri, E., Zanelli, M. & Merli, F., Sep 1 2019, In : World Journal of Clinical Cases. 7, 17, p. 2513-2518 6 p.

Research output: Contribution to journalArticle

Open Access
Hodgkin Disease
Skin
Biopsy
Dacarbazine
Axilla

Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL)

Salvi, F., Luminari, S., Tucci, A., Massidda, S., Liberati, A. M., Stelitano, C., Zanni, M., Re, A., Centurioni, R., Freilone, R., Musuraca, G., Nassi, L., Patti, C., Arcari, A., Tani, M., Pulsoni, A., Pavone, V., Volpetti, S., Peli, A., Evangelista, A. & 3 others, Spina, M., Ladetto, M. & Merli, F., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Dacarbazine
Vinblastine
Bleomycin
Hodgkin Disease
Radiotherapy
2 Citations (Scopus)

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study

Luminari, S., Merli, M., Rattotti, S., Tarantino, V., Marcheselli, L., Cavallo, F., Varettoni, M., Bianchi, B., Merli, F., Tedeschi, A., Cabras, G., Re, F., Visco, C., Torresan Delamain, M., Cencini, E., Spina, M., Ferrero, S., Ferrari, A., Deodato, M., Mannina, D. & 7 others, Annibali, O., Rago, A., Orsucci, L., Defrancesco, I., Frigeni, M., Cesaretti, M. & Arcaini, L., Sep 5 2019, In : Blood. 134, 10, p. 798-801 4 p.

Research output: Contribution to journalArticle

Disease Progression
Lymphoma
Survival
B-Cell Lymphoma
Follicular Lymphoma
1 Citation (Scopus)

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

FLYER Trial Investigators & German Lymphoma Alliance, Dec 21 2019, In : The Lancet. 394, 10216, p. 2271-2281 11 p.

Research output: Contribution to journalArticle